# FDA Inspection 807638 - Glaxo Wellcome Manufacturing Pte Limited - November 16, 2012

Source: https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/849162d6-7817-4728-99ca-6e47894e61bd
Source feed: FDA_Inspections

> FDA Inspection 807638 for Glaxo Wellcome Manufacturing Pte Limited on November 16, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 807638
- Company Name: Glaxo Wellcome Manufacturing Pte Limited
- Inspection Date: 2012-11-16
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1275331 - 2023-10-13](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/8cbb5aba-d1c2-41d9-a13b-4c75ff538297)
- [FDA Inspection 1191253 - 2022-09-02](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/4b957da9-8c89-41eb-963a-056f21d9dc0b)
- [FDA Inspection 1055375 - 2018-06-01](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/bb19f612-9f12-414c-b441-03e54b595aa4)
- [FDA Inspection 865559 - 2014-01-16](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/e90c7c12-5998-4d12-a365-18a1ea4a52eb)
- [FDA Inspection 572094 - 2009-03-13](https://www.keypedia.com/records/fda_inspections/glaxo-wellcome-manufacturing-pte-limited/8515a833-ea66-4963-a018-37e5b0ed757d)

Company: https://www.keypedia.com/companies/glaxo-wellcome-manufacturing-pte-limited/5bc5ffcf-9696-4708-86c1-f63fb5a0fc28

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c